Infliximab MeSH Descriptor Data 2025

MeSH Heading: Infliximab
Tree Number(s): D12.776.124.486.485.114.224.608; D12.776.124.790.651.114.224.537; D12.776.377.715.548.114.224.642
Unique ID: D000069285
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D000069285
Scope Note: A chimeric monoclonal antibody to TNF-ALPHA that is used in the treatment of RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; PSORIATIC ARTHRITIS and CROHN'S DISEASE.
Entry Term(s): Inflectra; Infliximab-abda; Infliximab-dyyb; MAb cA2; Monoclonal Antibody cA2; Remicade; Renflexis
Pharm Action: Dermatologic Agents
Gastrointestinal Agents
Antirheumatic Agents
Tumor Necrosis Factor Inhibitors
Related Numbers: 170277-31-3
See Also: Tumor Necrosis Factor-alpha
Public MeSH Note: 2016; INFLIXIMAB was indexed under ANTIBODIES, MONOCLONAL 1997-2015
History Note: 2016 (1997)
Date Established: 2016/01/01
Date of Entry: 2015/07/01
Revision Date: 2021/07/01

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

analysis (AN)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemistry (CH)

classification (CL)

drug effects (DE)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

therapeutic use (TU)

toxicity (TO)

ultrastructure (UL)

urine (UR)

Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
  - Blood Proteins [D12.776.124]
    - Immunoproteins [D12.776.124.486]
      - Immunoglobulins [D12.776.124.486.485]
        
        Antibodies [D12.776.124.486.485.114]
        
        Antibodies, Monoclonal [D12.776.124.486.485.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.124.486.485.114.224.060]
        
        Antibodies, Monoclonal, Murine-Derived [D12.776.124.486.485.114.224.075]
        
        Combined Antibody Therapeutics [D12.776.124.486.485.114.224.342]
        
        Infliximab [D12.776.124.486.485.114.224.608]
        
        Single-Chain Antibodies [D12.776.124.486.485.114.224.785]

Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
  - Blood Proteins [D12.776.124]
    - Serum Globulins [D12.776.124.790]
      - Immunoglobulins [D12.776.124.790.651]
        
        Antibodies [D12.776.124.790.651.114]
        
        Antibodies, Monoclonal [D12.776.124.790.651.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.124.790.651.114.224.060]
        
        Antibodies, Monoclonal, Murine-Derived [D12.776.124.790.651.114.224.075]
        
        Combined Antibody Therapeutics [D12.776.124.790.651.114.224.306]
        
        Infliximab [D12.776.124.790.651.114.224.537]

Amino Acids, Peptides, and Proteins [D12]
- Proteins [D12.776]
  - Globulins [D12.776.377]
    - Serum Globulins [D12.776.377.715]
      - Immunoglobulins [D12.776.377.715.548]
        
        Antibodies [D12.776.377.715.548.114]
        
        Antibodies, Monoclonal [D12.776.377.715.548.114.224]
        
        Antibodies, Monoclonal, Humanized [D12.776.377.715.548.114.224.200]
        
        Antibodies, Monoclonal, Murine-Derived [D12.776.377.715.548.114.224.284]
        
        Combined Antibody Therapeutics [D12.776.377.715.548.114.224.463]
        
        Infliximab [D12.776.377.715.548.114.224.642]

Infliximab Preferred

Remicade Narrower

Inflectra Narrower

Renflexis Narrower

Infliximab-dyyb Narrower

Infliximab-abda Narrower

page delivered in 0.157s